Provenance
Created by SPS, NHS England, the Royal College of Radiologists (RCR) and the Society of Radiographers (SoR), with the support of specialists working within clinical practice, for contrast agents commonly used in NHS England-commissioned radiology services.
PGD template attachment
The template PGDs are attached below to download and use in conjunction with our implementation advice.
Version 3.0 published
Version 3.0 of this PGD template has been published and is valid for use from January 2025. It has been published in advance of its valid from date to allow organisations time to take it through local governance processes.
Version 2.0 remains valid until the end of December 2024 – it will be removed from this webpage on expiry.
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice.
More Radiology PGDs
- Sodium chloride 0.9% in multi injector devices
- Ioversol (e.g. Optiray®) contrast agent
- Gadoxetate disodium (Primovist®) contrast agent
- Gadoteridol (ProHance®) contrast agent
- Gadobenate dimeglumine (MultiHance®) contrast agent
- Gadoteric acid meglumine contrast agent
- Gadobutrol (Gadovist®) contrast agent
- Iodixanol (e.g. Visipaque®) contrast agent
- Iohexol (e.g. Omnipaque®) contrast agent
- Iopamidol (e.g. Niopam®) contrast agent
All PGD templates
Templates
Update history
- V3.0 published
- Typo corrected.
- Title, URL and summary amended.
- V2.0 published and Version 1.2 removed as superseded.
- Published